Withanolide isolated from Physalis longifolia and analogs and methods of use thereof
US8598339B2 · kind B2 · utility
9Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2012 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Feb 1, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J61/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.